Haptoglobin phenotype and gestational diabetes

Diabetes Care

Volumn 27, Issue 9, 2004, Pages 2103-2107

  Mustafa, Stefan ^a   Vukovich, Thomas ^a   Prikoszovich, Thomas ^a   Winzer, Christine ^a   Schneider, Barbara ^b   Esterbauer, Harald ^a   Wagner, Oswald ^a   Kautzky Willer, Alexandra ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Institute for Medical Statistics   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HAPTOGLOBIN; PLASMA PROTEIN;

ADULT; ALLELISM; ANTIOXIDANT ACTIVITY; ARTICLE; CALCULATION; CAUCASIAN; CONFIDENCE INTERVAL; FEMALE; GENETIC VARIABILITY; HEMOGLOBIN DETERMINATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PREGNANCY DIABETES MELLITUS; PROTEIN ANALYSIS; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; VASCULAR DISEASE;

ADULT; AUSTRIA; DIABETES, GESTATIONAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HAPTOGLOBINS; HUMANS; ODDS RATIO; PHENOTYPE; PREGNANCY; REFERENCE VALUES; RISK FACTORS;

EID: 4444378329     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.9.2103     Document Type: Article

References (33)

1. Chiellini C, Bertacca A, Novelli SE, Gorgun CZ, Ciccarone A, Giordano A, Xu H, Soukas A, Costa M, Gandini D, Dimitri R, Bottone P, Cecchetti P, Pardini E, Perego L, Navalesi R, Folli F, Benzi L, Cinti S, Friedman JM, Hotamisligil GS, Maffei M: Obesity modulates the expression of haptoglobin in the white adipose tissue via TNFalpha. J Cell Physiol 190:251-258, 2002
2. McGill JR, Yang F, Baldwin WD, Brune JL, Barnett DR, Bowman BH, Moore CM: Localization of the haptoglobin alpha and beta genes (HPA and HPB) to human chromosome 16q22 by in situ hybridization. Cytogenet Cell Genet 38:155-157, 1984
3. Thomas L: Haptoglobin/hemopexin. In Clinical laboratory Diagnostics. 1st ed. Thomas L, Ed. Frankfurt, TH-Books, 1998, p. 663-667
4. Matsuoka H: Endothelial dysfunction associated with oxidative stress in human. Diabetes Res Clin Pract 54 (Suppl. 2):S65-S72, 2001
5. Anastasiou E, Lekakis JP, Alevizaki M, Papamichael CM, Megas J, Souvatzoglou A, Stamatelopoulos SF: Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes. Diabetes Care 21:2111-2115, 1998
6. Okazaki T, Nagai T: Difference in hemoglobin-binding ability of polymers among haptoglobin phenotypes (Letter). Clin Chem 43:2012-2013, 1997
7. Melamed-Frank M, Lache O, Enav BI, Szafranek T, Levy NS, Ricklis RM, Levy AP: Structure-function analysis of the antioxidant properties of haptoglobin. Blood 98:3693-3698, 2001
8. Bernard D, Christophe A, Delanghe J, Langlois M, De Buyzere M, Comhaire F: The effect of supplementation with an antioxidant preparation on LDL-oxidation is determined by haptoglobin polymorphism. Redox Rep 8:41-46, 2003
9. Langlois MR, Delanghe JR, De Buyzere ML, Bernard DR, Ouyang J: Effect of haptoglobin on the metabolism of vitamin C. Am J Clin Nutr 66:606-610, 1997
10. Delanghe J, Cambier B, Langlois M, De Buyzere M, Neels H, De Bacquer D, Van Cauwelaert P: Haptoglobin polymorphism, a genetic risk factor in coronary artery bypass surgery. Atherosclerosis 132:215-219, 1997
11. Delanghe J, Langlois M, Duprez D, De Buyzere M, Clement D: Haptoglobin polymorphism and peripheral arterial occlusive disease. Atherosclerosis 145:287-292, 1999
12. Densem CG, Wassel J, Brooks NH, Yonan N, Keevil B: Haptoglobin polymorphism influences the development of cardiac transplant vasculopathy. J Heart Lung Transplant 20:151, 2001
13. Nakhoul FM, Zoabi R, Kanter Y, Zoabi M, Skorecki K, Hochberg I, Leibu R, Miller B, Levy AP: Haptoglobin phenotype and diabetic nephropathy. Diabetologia 44:602-604, 2001
14. De Bacquer D, De Backer G, Langlois M, Delanghe J, Kesteloot H, Komitzer M: Haptoglobin polymorphism as a risk factor for coronary heart disease mortality. Atherosclerosis 157:161-166, 2001
15. Roguin A, Hochberg I, Nikolsky E, Markiewicz W, Meisel SR, Hir J, Grenadier E, Beyar R, Levy AP: Haptoglobin phenotype as a predictor of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 87:330-332, A9, 2001
16. Roguin A, Ribichini F, Ferrero V, Matullo G, Herer P, Wijns W, Levy AP: Haptoglobin phenotype and the risk of restenosis after coronary artery stent implantation. Am J Cardiol 89:806-810, 2002
17. Levy AP, Hochberg I, Jablonski K, Resnick HE, Lee ET, Best L, Howard BV: Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: the Strong Heart Study. J Am Coll Cardiol 40:1984-1990, 2002
18. Metzger BE, Coustan DR: Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus: the Organizing Committee. Diabetes Care 21 (Suppl. 2): B161-B167, 1998
19. Kjos SL, Buchanan TA: Gestational diabetes mellitus. N Engl J Med 341:1749-1756, 1999
20. Haffner SM, Miettinen H, Stern MP: Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men. Diabetologia 40:711-717, 1997
21. Pan WH, Cedres LB, Liu K, Dyer A, Schoenberger JA, Shekelle RB, Stamler R, Smith D, Collette P, Stamler J: Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 123:504-516, 1986
22. Engstrom G, Stavenow L, Hedblad B, Lind P, Eriksson KF, Janzon L, Lindgarde F: Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study. Diabetes 52:442-447, 2003
23. Kautzky-Willer A, Fasching P, Jilma B, Waldhausl W, Wagner OF: Persistent elevation and metabolic dependence of circulating E-selectin after delivery in women with gestational diabetes mellitus. J Clin Endocrinol Metab 82:4117-4121, 1997
24. Mittermayer F, Mayer BX, Meyer A, Winzer C, Pacini G, Wagner OF, Wolzt M, Kautzky-Willer A: Circulating concentrations of asymmetrical dimethyl-L-arginine are increased in women with previous gestational diabetes. Diabetologia 45:1372-1378, 2002
25. Orhan H, Onderoglu L, Yucel A, Sahin G: Circulating biomarkers of oxidative stress in complicated pregnancies. Arch Gynecol Obstet 267:189-195, 2003
26. Arbeitsgemeinschaft Diabetes und Schwangerschaft der deutschen Diabetesgesellschaft (DDG): Arbeitsgemeinschaft für Materno-Fetale Medizin (AGMFM) der DGGG und Deutsche Gesellschaft für Perinatale Medizin: Empfehlungen zu Diagnostik und Therapie des Gestationsdiabetes (GDM). Frauenarzt 42:891-899, 2001
27. Cooper DN, Nussbaum RL, Krawczak M: Proposed guidelines for papers describing DNA polymorphism-disease associations. Hum Genet 110:207-208, 2002
28. Yang SE, Min WK, Park H, Chun S, Nah J, Kim JQ: Distribution of haptoglobin phenotypes in a Korean population, using the semi-automated PhastSystem. Ann Clin Biochem 37:205-209, 2000
29. Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L: The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 17:189-212, 2001
30. Colditz GA, Willett WC, Stampfer MJ, Manson JE, Hennekens CH, Arky RA, Speizer FE: Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 132:501-513, 1990
31. Keaney JF, Jr, Larson MG, Vasan RS, Wilson PWF, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ: Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham study. Arterioscler Thromb Vasc Biol 23:434-439, 2003
32. Scheil HG, Scheffrahn W: [Haptoglobin (HPA)-subtypes in Swiss populations]. Anthropol Anz 56:25-30, 1998
33. Kanakoudi F, Drossou V, Tzimouli V, Diamanti E, Konstantinidis T, Germenis A, Kremenopoulos G: Serum concentrations of 10 acute-phase proteins in healthy term and preterm infants from birth to age 6 months. Clin Chem 41:605-608, 1995